Dr. Peter Marks, the top vaccine official at the FDA, has announced his resignation, criticizing Secretary of Health and Human Services Robert F. Kennedy Jr. for his approach to vaccine regulation. Marks, who became well-known during the Trump administration for his role in Operation Warp Speed, expressed his disappointment in a resignation letter, stating that the secretary prefers misinformation over truth and transparency.
Marks has been a key figure in the FDA’s vaccine policies, particularly during the rapid development of COVID-19 vaccines. His departure comes at a time of growing concern among public health experts about Kennedy’s leadership. The secretary has raised doubts about vaccine safety and effectiveness, leading to significant changes within the agency. An independent vaccine advisory committee meeting was recently canceled, and the National Institutes of Health stopped research on vaccine resistance and misinformation. Additionally, a vaccine critic has been appointed to conduct a controversial study linking vaccines to autism, a claim that has been widely discredited.
In response to Marks’s resignation, an HHS official stated that if he does not support the push for scientific integrity and transparency, he does not belong at the FDA. This statement reflects the tensions within the agency and the differing views on vaccine safety and public health.
Marks’s resignation has disappointed many in the scientific community. Dr. Ashish Jha, the former COVID-19 response coordinator, praised Marks as a dedicated scientist and public servant. Marks himself expressed sadness about leaving the FDA, noting the commitment of his staff to public health. He also warned about the dangers of undermining confidence in vaccines, especially as a measles outbreak in Texas grows, with at least 400 cases reported. He emphasized that vaccines provide essential protection against serious diseases.
Marks hopes that the current challenges to scientific truth will end, allowing the public to benefit from advances in medical science. His resignation marks a significant moment in the ongoing debate over vaccine policy and public health in the United States.